Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A143XJ | ISIN: US92915B1061 | Ticker-Symbol: VT6
Tradegate
27.03.24
15:22 Uhr
9,150 Euro
+0,500
+5,78 %
1-Jahres-Chart
VOYAGER THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VOYAGER THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
8,5008,85028.03.
8,4508,75028.03.

Aktuelle News zur VOYAGER THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiVoyager Therapeutics, Inc.: Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)22LEXINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment...
► Artikel lesen
19.03.Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform15
13.03.Voyager Therapeutics Appoints Toby Ferguson As Chief Medical Officer-
13.03.Voyager Therapeutics names ex-Biogen VP as new Chief Medical Officer1
13.03.Voyager Therapeutics, Inc.: Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer363LEXINGTON, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the appointment...
► Artikel lesen
13.03.Voyager Therapeutics, Inc. - 8-K, Current Report2
01.03.Earnings call: Voyager Therapeutics outlines CNS program progress6
29.02.Voyager Therapeutics rises on upbeat Q4 earnings14
29.02.Voyager Therapeutics Inc reports results for the quarter ended in December - Earnings Summary14
28.02.WW, DUOL and VYGR are among after hour movers8
28.02.Voyager Therapeutics, Inc.: Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results198- Company had approximately $431 million in pro-forma cash as of December 31, 2023, adjusted for $100 million consideration from Novartis agreements and $100 million public offering - - Strong cash...
► Artikel lesen
28.02.Voyager Therapeutics, Inc. - 8-K, Current Report4
27.02.Earnings Preview For Voyager Therapeutics8
26.02.Voyager Therapeutics, Inc.: Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich's Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment179LEXINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the joint...
► Artikel lesen
21.02.Voyager Therapeutics, Inc.: Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast7
20.02.Voyager Therapeutics, Inc.: Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer's Disease and Advances Program into Late Research194- Additional new data demonstrate VY-TAU01, Voyager's lead antibody targeting pathological tau, was well-tolerated and demonstrated favorable pharmacokinetics in non-human primates (NHPs) - - Data...
► Artikel lesen
07.02.Voyager Therapeutics, Inc.: Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference5
08.01.Voyager Therapeutics stock pops 30% on deal with Novartis23
05.01.US STOCKS Conagra Brands, Voyager Therapeutics, McDonald's16
05.01.Voyager Therapeutics slides as $100 million stock offering priced15
Seite:  Weiter >>
68 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3